Read More
Late-breaking TAILORx data to be presented at ESMO Congress 2019
New data from TAILORx, the federally funded, phase three clinical trial, will be presented as late-breaking information at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
Subscribe to:
Post Comments (Atom)
0 Response to "Late-breaking TAILORx data to be presented at ESMO Congress 2019"
Post a Comment